ethyl 2-[methyl-[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]amino]-5-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-4-carboxylate

C29H39N7O5S3Si — CID 155592581

IUPACethyl 2-[methyl-[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]amino]-5-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-4-carboxylate
SMILESCCOC(=O)c1nc(N(C)c2cc(C)c(/N=c3\sc4ccccc4n3COCC[Si](C)(C)C)nn2)sc1C1CN(S(C)(=O)=O)C1
InChIInChI=1S/C29H39N7O5S3Si/c1-8-41-27(37)24-25(20-16-35(17-20)44(4,38)39)43-28(30-24)34(3)23-15-19(2)26(33-32-23)31-29-36(18-40-13-14-45(5,6)7)21-11-9-10-12-22(21)42-29/h9-12,15,20H,8,13-14,16-18H2,1-7H3/b31-29-
InChIKeyKRZHUSKKKBTZDV-YCNYHXFESA-N
MW689.96 g/mol
LogP5.11
Rot. Bonds12

About ethyl 2-[methyl-[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]amino]-5-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-4-carboxylate

ethyl 2-[methyl-[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]amino]-5-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-4-carboxylate (PubChem CID 155592581) has the molecular formula C29H39N7O5S3Si and a molecular weight of 689.96 g/mol. Its IUPAC name is ethyl 2-[methyl-[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]amino]-5-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-4-carboxylate.

Molecular Properties

Compound Nameethyl 2-[methyl-[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]amino]-5-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-4-carboxylate
PubChem CID155592581
Molecular FormulaC29H39N7O5S3Si
Molecular Weight689.96 g/mol
Exact Mass689.19
IUPAC Nameethyl 2-[methyl-[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]amino]-5-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-4-carboxylate
SMILESCCOC(=O)c1nc(N(C)c2cc(C)c(/N=c3\sc4ccccc4n3COCC[Si](C)(C)C)nn2)sc1C1CN(S(C)(=O)=O)C1
InChIInChI=1S/C29H39N7O5S3Si/c1-8-41-27(37)24-25(20-16-35(17-20)44(4,38)39)43-28(30-24)34(3)23-15-19(2)26(33-32-23)31-29-36(18-40-13-14-45(5,6)7)21-11-9-10-12-22(21)42-29/h9-12,15,20H,8,13-14,16-18H2,1-7H3/b31-29-
InChIKeyKRZHUSKKKBTZDV-YCNYHXFESA-N
XLogP5.11
TPSA132.11 Ų
H-Bond Donors
H-Bond Acceptors13
Rotatable Bonds12
Heavy Atoms45
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500689.96
LogP ≤ 55.11
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze ethyl 2-[methyl-[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]amino]-5-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-4-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of ethyl 2-[methyl-[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]amino]-5-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-4-carboxylate?
The IUPAC name of ethyl 2-[methyl-[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]amino]-5-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-4-carboxylate (CID 155592581) is ethyl 2-[methyl-[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]amino]-5-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-4-carboxylate.
What is the SMILES notation for ethyl 2-[methyl-[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]amino]-5-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-4-carboxylate?
The canonical SMILES for ethyl 2-[methyl-[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]amino]-5-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-4-carboxylate is CCOC(=O)c1nc(N(C)c2cc(C)c(/N=c3\sc4ccccc4n3COCC[Si](C)(C)C)nn2)sc1C1CN(S(C)(=O)=O)C1.
What is the InChIKey of ethyl 2-[methyl-[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]amino]-5-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-4-carboxylate?
The InChIKey is KRZHUSKKKBTZDV-YCNYHXFESA-N. The full InChI is InChI=1S/C29H39N7O5S3Si/c1-8-41-27(37)24-25(20-16-35(17-20)44(4,38)39)43-28(30-24)34(3)23-15-19(2)26(33-32-23)31-29-36(18-40-13-14-45(5,6)7)21-11-9-10-12-22(21)42-29/h9-12,15,20H,8,13-14,16-18H2,1-7H3/b31-29-.
What are the key properties of ethyl 2-[methyl-[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]amino]-5-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-4-carboxylate?
ethyl 2-[methyl-[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]amino]-5-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-4-carboxylate has a molecular weight of 689.96 g/mol, XLogP of 5.11, 12 rotatable bonds, 0 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for ethyl 2-[methyl-[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]amino]-5-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-4-carboxylate is sourced from PubChem (CID 155592581), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).